South African medical technology innovation sees successful maiden use in the US

University of Cape Town- (UCT-) based South African medical technology company Strait Access Technologies (SAT) reported on Monday that its CenterFlow balloon dilation catheter had been used in humans for the first time. The first two surgeries using the device had both been conducted in the US, at Massachusetts General Hospital in Boston and Jefferson University Hospital in Philadelphia, Pennsylvania. “This first use in patients confirms that CentreFlow has real clinical value and the potential to change how aortic aneurysms are treated,” affirmed SAT founder and chief medical officer Dr Peter Zilla. “By extending the treatment window from seconds to minutes while maintaining stability and radial force, it represents a meaningful advance in patient care.”